Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Op-Eds
Science vs. Presumption In Assessing Risk
Full Chapter Available in PDF Format On September 22, 2000, California Governor Gray Davis signed into…
Op-Eds
European move will stifle GMOs
Regulatory officials in the European Union seem to be ignorant of the Rule of Holes: When you're in a hole, stop digging. Repeated analyzes…
Op-Eds
Blessed Are The Poor With Spirit
This year's UN-sponsored World Food Summit just concluded with a grim reminder that the goal of cutting world hunger in half by 2015 set six…
Op-Eds
Biotech Critics Find A Little Goes A Long Way
In the fictional world of James Bond, the criminal group SPECTRE made a big business out of misusing technology to disrupt commerce, make money, and…
Comment
Are Risk Assessment And The Precautionary Principle Equivalent?
EDITOR’S NOTE: The following paper was prepared for the June 20-21, 2002 International Society of Regulatory Toxicology and Pharmacology workshop on the Precautionary Principle,…
Op-Eds
Want to Avoid GM Foods? This Regulation Won’t Help
Yesterday, the European Parliament’s Environment Committee voted to expand the EU’s labelling requirement for Genetically Modified foods. The measure, in the form of…